Several key glycolytic enzymes that regulate glucose metabolism and associated pathways have been widely reported in cancers, including ALDOA, ENO1, HK2, LDH, PFK1, PGAM1, PGK1, PKM2 and TPI1 [38,39,40,41]. This evidence concerns the gene ALDOA and cancer.